The global stem cell services market is expected to grow at a CAGR of 8.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing demand for stem cells in research and development, rising prevalence of chronic diseases, and technological advancements in the field of regenerative medicine. Customize service segment accounted for the largest share of the global stem cell services market in 2018. This segment is expected to continue its dominance throughout the forecast period owing to its ability to provide customized solutions for various applications such as drug discovery and development, clinical trials, and personalized medicine. Stem cell differentiation segment accounted for a significant share of this market in 2018 due to its ability to differentiate into various types of cells including neurons, cardiomyocytes, hepatocytes etc, which are used extensively in research and development activities across different industries such as pharmaceuticals and biotechnology. Assay development segment accounted for a significant share of this market owing to its ability to develop assays that can be used by researchers across different industries such as pharmaceuticals and biotechnology. Screening segment accounted for a significant share due it being able to screen potential drugs or therapies before they are tested on humans or animals through animal models or clinical trials respectively; thereby reducing risks associated with testing new drugs on humans or animals respectively without prior knowledge about their efficacy or safety profile. Stem cell service was also an important contributor towards this market owing mainly due it being able to provide services related with stem cells including banking (stem cells), storage (stem cells), processing (stem cells) etc, which are used extensively by hospitals across different regions globally. -The global Stem Cell Services market is expected to grow at a CAGR of 8.2% during the forecast period, from USD 3.5 billion in 2017 to USD 5.6 billion by 2022. -The global Stem Cell Services market is driven by factors such as increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in stem cell research.
Industry Growth Insights published a new data on “Stem Cell Services Market”. The research report is titled “Stem Cell Services Market research by Types (Customize Service, Stem Cell Differentiation, Assay Development, Screening, Others, Stem Cell Service), By Applications (Hospital, Research Institute, Others), By Players/Companies Paragon Bioservices, APEX Biologix, VcanBio, Cryo-cell, Crioestaminal, LifeCell, ViaCord, Pepro Tech, Health Baby, Stem Cell Service”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Stem Cell Services Market Research Report
By Type
Customize Service, Stem Cell Differentiation, Assay Development, Screening, Others, Stem Cell Service
By Application
Hospital, Research Institute, Others
By Companies
Paragon Bioservices, APEX Biologix, VcanBio, Cryo-cell, Crioestaminal, LifeCell, ViaCord, Pepro Tech, Health Baby, Stem Cell Service
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Stem Cell Services Market Report Segments:
The global Stem Cell Services market is segmented on the basis of:
Types
Customize Service, Stem Cell Differentiation, Assay Development, Screening, Others, Stem Cell Service
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Research Institute, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Paragon Bioservices
- APEX Biologix
- VcanBio
- Cryo-cell
- Crioestaminal
- LifeCell
- ViaCord
- Pepro Tech
- Health Baby
- Stem Cell Service
Highlights of The Stem Cell Services Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Customize Service
- Stem Cell Differentiation
- Assay Development
- Screening
- Others
- Stem Cell Service
- By Application:
- Hospital
- Research Institute
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Stem Cell Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Stem cell services are treatments that use stem cells to help heal or prevent injuries. These treatments can be used to treat a variety of conditions, including cancer, spinal cord injury, and cerebral palsy.
Some of the major companies in the stem cell services market are Paragon Bioservices, APEX Biologix, VcanBio, Cryo-cell, Crioestaminal, LifeCell, ViaCord, Pepro Tech, Health Baby, Stem Cell Service.
The stem cell services market is expected to register a CAGR of 8.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Stem Cell Services Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Stem Cell Services Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Stem Cell Services Market - Supply Chain
4.5. Global Stem Cell Services Market Forecast
4.5.1. Stem Cell Services Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Stem Cell Services Market Size (000 Units) and Y-o-Y Growth
4.5.3. Stem Cell Services Market Absolute $ Opportunity
5. Global Stem Cell Services Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Stem Cell Services Market Size and Volume Forecast by Type
5.3.1. Customize Service
5.3.2. Stem Cell Differentiation
5.3.3. Assay Development
5.3.4. Screening
5.3.5. Others
5.3.6. Stem Cell Service
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Stem Cell Services Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Stem Cell Services Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Research Institute
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Stem Cell Services Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Stem Cell Services Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Stem Cell Services Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Stem Cell Services Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Stem Cell Services Demand Share Forecast, 2019-2026
9. North America Stem Cell Services Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Stem Cell Services Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Stem Cell Services Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Research Institute
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Stem Cell Services Market Size and Volume Forecast by Type
9.7.1. Customize Service
9.7.2. Stem Cell Differentiation
9.7.3. Assay Development
9.7.4. Screening
9.7.5. Others
9.7.6. Stem Cell Service
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Stem Cell Services Demand Share Forecast, 2019-2026
10. Latin America Stem Cell Services Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Stem Cell Services Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Stem Cell Services Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Research Institute
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Stem Cell Services Market Size and Volume Forecast by Type
10.7.1. Customize Service
10.7.2. Stem Cell Differentiation
10.7.3. Assay Development
10.7.4. Screening
10.7.5. Others
10.7.6. Stem Cell Service
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Stem Cell Services Demand Share Forecast, 2019-2026
11. Europe Stem Cell Services Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Stem Cell Services Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Stem Cell Services Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Research Institute
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Stem Cell Services Market Size and Volume Forecast by Type
11.7.1. Customize Service
11.7.2. Stem Cell Differentiation
11.7.3. Assay Development
11.7.4. Screening
11.7.5. Others
11.7.6. Stem Cell Service
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Stem Cell Services Demand Share, 2019-2026
12. Asia Pacific Stem Cell Services Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Stem Cell Services Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Stem Cell Services Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Research Institute
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Stem Cell Services Market Size and Volume Forecast by Type
12.7.1. Customize Service
12.7.2. Stem Cell Differentiation
12.7.3. Assay Development
12.7.4. Screening
12.7.5. Others
12.7.6. Stem Cell Service
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Stem Cell Services Demand Share, 2019-2026
13. Middle East & Africa Stem Cell Services Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Stem Cell Services Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Stem Cell Services Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Research Institute
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Stem Cell Services Market Size and Volume Forecast by Type
13.7.1. Customize Service
13.7.2. Stem Cell Differentiation
13.7.3. Assay Development
13.7.4. Screening
13.7.5. Others
13.7.6. Stem Cell Service
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Stem Cell Services Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Stem Cell Services Market: Market Share Analysis
14.2. Stem Cell Services Distributors and Customers
14.3. Stem Cell Services Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Paragon Bioservices
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. APEX Biologix
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. VcanBio
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Cryo-cell
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Crioestaminal
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. LifeCell
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. ViaCord
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Pepro Tech
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Health Baby
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Stem Cell Service
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook